Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health

Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health

The intestinal microbiota, hosting trillions of microorganisms that inhabit the gastrointestinal tract, functions as a symbiotic organism that plays a crucial role in regulating health by producing biologically active molecules that can enter systemic circulation. Among them, trimethylamine-N-oxide...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eugenio Caradonna, Federico Abate, Elisabetta Schiano, Francesca Paparella, Fulvio Ferrara, Emilio Vanoli, Rossana Difruscolo, Vito Maria Goffredo, Bruno Amato, Carlo Setacci, Francesco Setacci, Ettore Novellino
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Series:	Metabolites
Subjects:	trimethylamine-N-oxide (TMAO) gut microbiota cardiovascular diseases atherosclerosis endothelial dysfunction neurodegenerative diseases
Online Access:	https://www.mdpi.com/2218-1989/15/4/220
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TMAO metaorganismal pathway and chronic inflammatory diseases
by: Zeneng Wang, et al.
Published: (2025-06-01)

Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
by: Ylenia Heinrich-Sanchez, et al.
Published: (2025-12-01)

Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis
by: Matthew J. Budoff, et al.
Published: (2025-07-01)

Trimethylamine N-oxide generation process was influenced by the proportion and source of macronutrients in the diet
by: Chengcheng Wang, et al.
Published: (2024-03-01)

Associations of first-trimester TMAO and its precursors with gestational diabetes mellitus: a pilot prospective cohort study
by: Geng-Dong Chen, et al.
Published: (2025-06-01)

Interrelationships of the Intestinal Microbiome, Trimethylamine N-Oxide and Lipopolysaccharide-Binding Protein with Crohn’s Disease Activity
by: Yelena Laryushina, et al.
Published: (2024-12-01)

Trimethylamine N-Oxide (TMAO) Acts as Inhibitor of Endothelial Nitric Oxide Synthase (eNOS) and Hampers NO Production and Acetylcholine-Mediated Vasorelaxation in Rat Aortas
by: Alma Martelli, et al.
Published: (2025-04-01)

Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)

Probiotic Bifidobacterium reduces serum TMAO in unstable angina patients via the gut to liver to heart axis
by: Zhihong Zhou, et al.
Published: (2025-03-01)

The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases
by: Majid Eslami, et al.
Published: (2024-10-01)

Interaction studies unveil potential binding sites on bovine serum albumin for gut metabolite trimethylamine n-oxide (TMAO)
by: Awadhesh Kumar Verma, et al.
Published: (2025-01-01)

Effect of Rifaximin and a Multi-Strain Probiotic on the Intestinal Microbiome and Cardiovascular Risk Indicators in Patients with Coronary Heart Disease
by: E. A. Kashukh, et al.
Published: (2019-09-01)

Research advances of trimethylamine N-oxide and chronic kidney diseases
by: Liu Mei-jun, et al.
Published: (2021-01-01)

Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01)

TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
by: Si Hyoung Kim, et al.
Published: (2025-12-01)

Trimethylamine N-oxide, S-equol, and indoxyl sulfate inflammatory microbiota players in ocular Behçet’s disease
by: Arslan Sermal, et al.
Published: (2024-12-01)

Research progress on the association between TMAO and vascular calcification in patients with chronic kidney disease
by: Yuxin Zhang, et al.
Published: (2024-12-01)

Prospects for the sulfur-containing amino acids medicines usage for trimethylamine-N-oxide biosynthesis modulation in humans
by: I. O. Melnychuk, et al.
Published: (2023-01-01)

Tanshinone regulated gut microbiota and TMAO to improve high-fat diet induced atherosclerosis in APOE−/− mice
by: Aiming Zhou, et al.
Published: (2025-07-01)

The Impact of Trimethylamine N-Oxide on Atrial Fibrillation Presence in Patients with Cardiovascular Disease
by: Cristian Marius Florea, et al.
Published: (2025-02-01)

The microbial metabolite trimethylamine N-oxide and the kidney diseases
by: Jin-Qi Su, et al.
Published: (2025-03-01)

Conclusion on the peer review of the pesticide risk assessment of the active substance trimethylamine hydrochloride
by: European Food Safety Authority
Published: (2012-01-01)

Exploring the trimethylamine-degrading genes in the human gut microbiome
by: Yi-Ran Chen, et al.
Published: (2025-06-01)

Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease
by: Siyu Wang, et al.
Published: (2025-07-01)

Development and Application of a UPLC–MRM–MS Method for Quantifying Trimethylamine, Trimethylamine-N-Oxide, and Related Metabolites in Individuals with and Without Metabolic Syndrome
by: Mohammed E. Hefni, et al.
Published: (2025-02-01)

Plasma TMAO Concentrations and Gut Microbiota Composition in Subjects with and Without Metabolic Syndrome: Results from Pilot Study
by: Mohammed E. Hefni, et al.
Published: (2025-05-01)

Gut Microbiota-Derived Trimethylamine Promotes Inflammation with a Potential Impact on Epigenetic and Mitochondrial Homeostasis in Caco-2 Cells
by: Laura Bordoni, et al.
Published: (2024-08-01)

Prediction value of serum TMAO on myocardial injury after PCI in patients with coronary heart disease based on decision curve analysis
by: CHEN Guixiu，GUO Cheng，HE Lin
Published: (2025-08-01)

Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01)

Comparison of short-term and long-term effects of peroral L-carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications
by: Harsahaj Singh Wilkhoo, et al.
Published: (2025-02-01)

The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine
by: Zizhen Qin, et al.
Published: (2025-07-01)

TMAO Induces Vascular Endothelial Cells Pyroptosis Through TET2-CYTB-ROS Pathway
by: Xia L, et al.
Published: (2025-07-01)

Effects of prebiotics and phytochemicals on serum trimethylamine N-oxide reduction and gut microbiota: a systematic review and meta-analysis
by: Zheng-Wei Wan, et al.
Published: (2025-07-01)

Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
by: Zhen Li, et al.
Published: (2024-11-01)

TMAO is involved in sleep deprivation-induced cognitive dysfunction through regulating astrocytic cholesterol metabolism via SREBP2
by: Shan Zhu, et al.
Published: (2024-11-01)

Tanyu Tongzhi decoction ameliorates atherosclerosis by inhibiting trimethylamine N-oxide-induced vascular inflammation via PI3K/Akt/NF-κB pathway regulation
by: Yingying Li, et al.
Published: (2025-03-01)

Trimethylamine oxide and its possible role in the development and progression of cardiovascular disease
by: A. I. Kochetkov, et al.
Published: (2021-10-01)

Potential Effects of Exercise-Induced Alterations in the Gut Microbiome and Its Metabolites on Cerebrovascular Health and Alzheimer's Disease
by: Da-Hui Sim, et al.
Published: (2024-11-01)

Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons
by: Liu J, et al.
Published: (2025-04-01)

Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01)